Marimed (MRMD) Profit After Tax (2011 - 2026)

Marimed (MRMD) has 16 years of Profit After Tax data on file, last reported at -$3.8 million in Q1 2026.

• On a quarterly basis, Profit After Tax rose 30.92% year-over-year to -$3.8 million in Q1 2026; TTM through Mar 2026 was -$12.8 million, a 22.92% increase from a year earlier, with the FY2025 full-year figure at -$14.5 million, down 15.95% from the prior year.
• Profit After Tax for Q1 2026 stood at -$3.8 million, up from -$4.6 million in the prior quarter.
• Over the last five years, Profit After Tax for MRMD reached as high as $4.6 million in Q4 2022 and fell as low as -$10.2 million in Q4 2023.
• Historically, Profit After Tax has averaged -$2.0 million across 5 years, with a median of -$1.4 million in 2024.
• Across the five-year window, Profit After Tax surged 175.45% in 2022 and tumbled 320.63% in 2023, its largest moves.
• Year by year, Profit After Tax stood at $4.6 million in 2022, then slumped by 320.63% to -$10.2 million in 2023, then rose by 18.37% to -$8.3 million in 2024, then soared by 44.09% to -$4.6 million in 2025, then advanced by 18.44% to -$3.8 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$3.8 million in Q1 2026, -$4.6 million in Q4 2025, and -$2.9 million in Q3 2025.